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Abstract 
Intra-cardiac masses present an important problem in cardiology. The differential diagnoses includes tumours, which may be primary 
(benign or malignant) or metastatic, and infected mural thrombi.
Myxomas, sarcomas, breast, lung and renal cancer represent the commonest causes of primary benign, malignant and metastatic intra-
cardiac masses, respectively. 
Recent studies have shown that cardiac involvement in malignant lymphoma is common but under-investigated. 
Diagnostic imaging techniques for detection of cardiac masses include echocardiography, CT and MRI, with echocardiography having 
the highest sensitivity. We propose that 18-F-PET/CT may play an important role in the detection and evaluation of intra-cardiac masses. 
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Case report
A 60-year-old gentleman was referred for an [
18F]FDG-PET/CT 
to evaluate the relapse of a diffuse non-Hodgkin large B cell 
lymphoma initially localized in the right testis, retroperitoneal 
lymph nodes and right lung. Previous treatment included a right-
sided orchidectomy and a right-sided lobectomy, chemotherapy 
and immunotherapy. 
An [
18F]FDG-PET/CT scan showed no focal abnormalities apart 
from a dubious lesion in the right atrium (SUVbw max 12) 
(Figure1), which was not reported following a contrast enhanced 
CT scan (ceCT) performed one month earlier (Figure 2) and a 
second CT scan performed one month later. 
[
18F]FDG-PET/CT and ceCT scans were repeated 
approximately three months later. The [
18F]FDG-PET/CT scan 
confirmed the presence of a right-atrial lesion which, when 
compared to the previous PET/CT scan, had increased in both 
size and uptake, with a maximal standardized uptake value 
(SUV bw max) now of 24. Pulmonary lesions were also reported 
(Figure 3). The ceCT scan showed a right-atrial mass of 
approximately 5.7 cm in diameter together with the pulmonary 
lesions (Figure 4). 
A trans-thoracic echo Doppler further reported the presence of a 
dishomogenous hyperecogenic mass in the right atrium. 
In view of the poor clinical condition of the patient, no 
histological diagnosis of the atrial mass was made although 
disease progression involving the heart was strongly suspected. 
 
Discussion 
Intra-cardiac masses present an important problem in 
cardiology. The differential diagnosis includes tumours and 
infected mural thrombi. 
Cardiac tumours are classified as primary benign or malignant 
tumours that arise from the heart, or as secondary metastatic 
tumours that invade the heart. Primary cardiac tumours occur 
with a low incidence. It is estimated that secondary metastatic 
tumours are a hundred times more common than primary 
cardiac lesions [1]. 
Over 75% of primary cardiac neoplasms are benign and are 
represented by myxomas and rhabdomyosarcomas. Myxomas 
are the most common, and 75% of these occurr in the left 
atrium, 20% are in the right atrium and the rest in the ventricles. 
Rhabdomyosarcomas are exceedingly rare and are more 
frequent in young patients. They typically involve the cardiac 
valves and invade the pericardium [2]. Other examples of 
benign cardiac tumours include haemangiomas, teratomas, 
lipomas, paragangliomas and pericardiac cysts. 
Malignant primary tumours include sarcomas, pericardial 
mesothelioma and primary lymphomas. Sarcoma is the most 
common malignant and the second most common primary 
cardiac tumour affecting mainly middle-aged adults. 
Approximately, 40% are angiosarcomas [3]. Other types include 
undifferentiated sarcoma, malignant histiosarcoma, 
leomyosarcoma, fibrosarcoma, liposarcoma and osteosarcoma. 
Both pericardial mesothelioma and primary lymphoma are 
extremely rare with the latter usually occurring in 
immunocompromised patients. 
Lung, breast and renal cancer together with soft-tissue sarcoma 
are the most common sources of metastasis to the heart [3]. 
Cardiac involvement in malignant lymphoma (as suspected in 
the case described above) is one of the least investigated areas 
of oncology [4]. A review of the current literature indicates that 
the incidence of cardiac involvement from lymphoma as 
identified by autopsy varies widely, ranging from 8.7% to 20% 
[5]. Although metastatic cardiac lymphoma can be symptomatic 
(arrhythmias, heart failure), clinical signs and symptoms are 
often absent or non-specific, and in most cases cardiac 
involvement in lymphomas remains undetected prior to the 
patient's death. 
Two-dimensional echocardiography is regarded as the primary 
diagnostic imaging technique for the evaluation of cardiac 
masses, with a diagnostic sensitivity of 93% for trans-thoracic 
echocardiography and 97% for trans-oesophageal 
echocardiography, although Qingyi et al reported a sensitivity of 
only 75.9% for the detection of cardiac metastasis [4]. 
Magnetic resonance (MR) has emerged as a useful tool for 
detailed evaluation of cardiac masses since it has a large field 
of view and allows for direct multi-planar imaging. An advantage 
of MR over echocardiography is its ability to obtain a tissue 
diagnosis in many cases [6]. 
Nuclear medicine techniques previously employed to detect 
cardiac tumours include blood pool imaging and gallium or 
thallium scintigraphy [7]. [
18F]FDG-PET/CT has already been 
shown to be more accurate than CT in the evaluation of 
lymphomas and other tumours, especially in the follow-up of 
patients previously treated with chemotherapy and/or
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Figure 1: First [
18F]FDG-PET/CT scan showing a suspicious uptake in the right atrium (SUV bw max 12).
 
Figure 2: First CT scan performed in which no atrial lesion was reported.
 3  www.ecancermedicalscience.com 
C
a
s
e
 
R
e
p
o
r
t
s
 ecancer 2009, 3:152 
 
 
 
Figure 3: Second [
18F]FDG-PET/CT scan, performed three months later, showing right atrial uptake (SUV bw max 24) together with pulmonary 
lesions. 
 
Figure 4: Second CT scan showing a right-atrial mass, measuring 5.7 cm in diameter together with pulmonary lesions. 
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radiotherapy. [
18F]FDG-PET/CT may have the advantage of 
detecting the tumour or metastases at an early stage, and in 
cases such as the one described above, it may help in the 
differentiation between benign and malignant lesions of the 
heart, which is difficult with other imaging modalities. 
We report the first case of cardiac involvement in malignant 
lymphoma, which was diagnosed earlier by [
18F]FDG-PET/CT 
than by ceCT. Early detection of metastatic cardiac involvement 
is important for proper diagnostic and therapeutic inter- 
ventions. 
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